Stephens & Co. analyst Jack Atkins maintains Kirby (NYSE:KEX) with a Overweight and raises the price target from $85 to $90.
Why Is Preterm Birth Risk Kit Focused Sera Prognostics Stock Trading Higher Today?
Sera Prognostics Inc (NASDAQ: SERA) announced that the Data Safety Monitoring Board (DSMB) overseeing its pivotal PRIME study recommended stopping enrollment due to efficacy, reporting that either of the co-primary endpoints met the stopping criteria for statistical significance at the pre-
